Gamechanger

Confocal.nl: groundbreaking microscope technology for research in living cells

Living cells mouse inner ear_Confocal_ROMinwest

Confocal.nl

Facts

Mission:
More effective medicines thanks to better cell research

Fund: SME Fund

Contributes to SDG(s):

 

Mouse thyroid cells

Research into structural changes in living cells is taking off in the medical world. Unfortunately, the existing technology requires researchers to undergo long and intensive training in microscopy. Furthermore, cell research on a microscopic scale is traditionally done with intense laser light, which damages and eventually kills living cells. As a result, living cells can usually only be studied to a limited extent.

The high-quality microscopes of Confocal.nl are more user-friendly than existing technology and can be easily connected to existing microscopes. They are also very economical with laser light despite their super high resolution. In this way, Confocal.nl efficiently creates many more possibilities with existing medical equipment.

Living cells mouse inner ear_Confocal_ROMinwest
“Thanks to the investment from ROM InWest, we can further automate the products made with our basic technology. This will make them even more accessible to the international scientific and industrial R&D community. The money will also serve our expansion on a commercial level, with which we want to increase our brand awareness in order to achieve further increasing sales figures – so that we can ultimately finance our own growth.”
Pim Vos - profile picture
Pim Vos
CEO Confocal.nl

Investment ROM InWest

“Live cell imaging is a rapidly emerging and promising technology for the global fight against diseases such as cancer,” says Janet Nieboer, CEO of ROM InWest. “With their unique microscopes, Confocal.nl makes this technology widely accessible to researchers worldwide. The more targeted and effective treatment methods that we contribute to with our investment in Confocal.nl, in turn, lead to lower healthcare costs. The entire society benefits from this.”

Let you
Inspire

November 29, 2024

LSH Capital Match 2024: the matchmaking event in the life sciences & health sector

News
On November 28, 2024, the annual LSH Capital Match took place in the Health & Innovation District in Amsterdam, the...
25 October 2024

“More entrepreneurship within Life Sciences & Health is an urgent necessity”

Interviews
As in the rest of the Netherlands, the pressure on North Holland healthcare is growing rapidly. What does this sector need...
October 17, 2024

ROM InWest invests in Confocal.nl for growth in live-cell microscopy

News
ROM InWest is investing 5 million euros in Amsterdam-based microscope manufacturer Confocal.nl together with Nascent Ventures. The technology of...

Our
game changers

Our
game-
changers

Drystack has developed a circular and demountable dry-stack system for bricks. By replacing cement with a smart click system, Drystack 100% creates circular facades: demountable, reusable, and built in a...

LinXis is developing a technology that allows it to detect and treat fibrosis more specifically. With this, it aims to offer a solution for millions of people worldwide with this serious condition.

Globally, around 40 million people live with severe blindness. Phosphoenix is developing a brain implant (neuroprosthetic system) that can restore functional vision using AI in people who later in life...

Greencovery has a sustainable solution to reuse residual streams from the food industry and convert them into valuable ingredients. In this way, a cost item, waste processing of residual materials, is transformed into an extra...

Phoenix Metals is an innovative company that recovers valuable raw materials from industrial waste streams such as steel slag, thereby playing an innovative role in the battery market.

Droppie was founded by Natascha Hermsen and Stef Traa and cleverly collects waste via special recycling shops, where consumers receive money for plastic packaging, textiles, cooking oil and...

Root Sustainability develops AI technology that allows retailers to make smart decisions based on product-specific data to concretely reduce the CO2 footprint in their supply chain. Dispersed data is quickly and efficiently...

Methotrexate is currently the most commonly prescribed basic drug for rheumatoid arthritis worldwide. Sixty to eighty per cent of patients receive this drug. The problem, however, is that methotrexate is too...

Stay tuned

Subscribe to our newsletter and stay up to date with news, stories, relevant events and more.